Inari Medical, Inc. (NARI)

NASDAQ: NARI · IEX Real-Time Price · USD
77.35 -0.54 (-0.69%)
Jan 18, 2022 2:29 PM EST - Market open
Market Cap3.88B
Revenue (ttm)242.38M
Net Income (ttm)15.72M
Shares Out50.20M
EPS (ttm)0.28
PE Ratio272.36
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume395,192
Open76.10
Previous Close77.89
Day's Range75.00 - 79.27
52-Week Range68.44 - 127.42
Betan/a
AnalystsStrong Buy
Price Target121.00 (+56.4%)
Earnings DateNov 9, 2021

About NARI

Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It offers ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was founded in 2011 and is headquartered in Irvine, California.

IndustryHealth Care Equipment & Supplies
IPO DateMay 22, 2020
Employees456
Stock ExchangeNASDAQ
Ticker SymbolNARI
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for Inari Medical stock is "Strong Buy." The 12-month stock price forecast is 121.00, which is an increase of 56.43% from the latest price.

Price Target
$121.00
(56.43% upside)
Analyst Consensus: Strong Buy

News

Inari Medical (NARI) Posts Solid Preliminary Q4, FY2021 Revenues

Inari Medical (NARI) posts solid fourth-quarter and full-year 2021 revenue data, courtesy of resilience shown in the face of the COVID-19 induced challenges.

2 hours ago - Zacks Investment Research

Inari Medical Reports Solid Preliminary Q4, FY21 Sales

Inari Medical Inc (NASDAQ: NARI) expects Q4 FY21 sales of $82.8 million - $83.3 million, up 14% sequentially and 71% year-over-year (at the midpoint of the range), beating the consensus of $73.16 millio...

1 week ago - Benzinga

Inari Medical Reports Preliminary Fourth Quarter 2021 Revenue

IRVINE, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffe...

1 week ago - GlobeNewsWire

Inari Medical to Present at the 40th Annual J.P. Morgan Healthcare Conference

IRVINE, Calif., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffe...

2 weeks ago - GlobeNewsWire

3 High-Growth Stocks Wall Street Thinks Could Rise 50% or More

Huge gains could be up ahead if the rest of the market sees these stocks in the same light as investment bank analysts.

Other symbols:MARASQ
1 month ago - The Motley Fool

3 COVID-19 Stocks That Should Beat the Market in 2022

Our Foolish roundtable has three stocks to invest in as we enter our third year of the COVID pandemic.

Other symbols:MRNANVAX
1 month ago - The Motley Fool

3 Unstoppable Growth Stocks You Can Buy for Less Than $100 Right Now

It doesn't take a lot to own a piece of these rapidly growing healthcare businesses.

Other symbols:CDNANVRO
1 month ago - The Motley Fool

New Strong Sell Stocks for November 10th

AZN, GOLD, NARI, KOP, and TCEHY have been added to the Zacks Rank #5 (Strong Sell) List on November 10, 2021.

Other symbols:AZNGOLDKOPTCEHY
2 months ago - Zacks Investment Research

Inari Medical (NARI) Q3 Earnings and Revenues Beat Estimates

Inari Medical's (NARI) third-quarter results benefit from new product launches and continued U.S. commercial expansion.

2 months ago - Zacks Investment Research

Inari Medical, Inc. (NARI) Reports Q3 Loss, Tops Revenue Estimates

Inari Medical, Inc. (NARI) delivered earnings and revenue surprises of 45.45% and 17.30%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Recap: Inari Medical Q3 Earnings

Inari Medical (NASDAQ:NARI) reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:01 PM. Here's what investors need to know about the announcement.

2 months ago - Benzinga

Inari Medical Reports Third Quarter 2021 Financial Results

IRVINE, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffe...

2 months ago - GlobeNewsWire

Earnings Preview: Inari Medical, Inc. (NARI) Q3 Earnings Expected to Decline

Inari Medical, Inc. (NARI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

Inari Medical Announces 6-month FLASH Registry Interim Data Demonstrating Benefits of Lytic-Free Mechanical Thrombect...

IRVINE, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffer...

2 months ago - GlobeNewsWire

Inari Medical to Announce Third Quarter 2021 Financial Results

IRVINE, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives ...

2 months ago - GlobeNewsWire

Top 5 Trades of the Eaton Vance Worldwide Health Sciences Fund

The Eaton Vance Worldwide Health Sciences Fund (Trades, Portfolio) disclosed its portfolio for the third quarter of the year earlier this week.

Other symbols:CNCIXJVRTX
2 months ago - GuruFocus

3 Under-the-Radar COVID Stocks

Some COVID-19 stocks are pretty famous. But other lesser-known names are flying high, too.

Other symbols:CYRXOCGN
2 months ago - The Motley Fool

Inari Medical Announces Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System in Pulmon...

IRVINE, Calif., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffer...

3 months ago - GlobeNewsWire

President And CEO Of Inari Medical Makes $2.4M Sale

William Hoffman, President And CEO at Inari Medical (NASDAQ:NARI), made a large insider sell on October 7, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exch...

3 months ago - Benzinga

Reasons to Hold on to Inari Medical (NARI) Stock For Now

Investors continue to be optimistic about Inari Medical (NARI) owing to its focus on understanding the venous system and its commitment toward patient care.

3 months ago - Zacks Investment Research

Inari Medical Appoints Dana G. Mead, Jr. to Board of Directors

IRVINE, Calif., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffe...

3 months ago - GlobeNewsWire

3 Top Healthcare Stocks You Can Buy for $100 or Less

It doesn't take a lot of upfront cash to add one of these stocks to your portfolio.

Other symbols:FLGTTDOC
4 months ago - The Motley Fool

American Airlines Group Inc Ranked Among Today's Top Shorts As COVID-19 Concerns Continue To Rise

The Dow rose about 210 points, the S&P 500 rebounded by 0.6%, and the Nasdaq added another 0.6%. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.

Other symbols:AALBYNDSABR
4 months ago - Forbes

Why Is Inari Medical, Inc. (NARI) Up 8.8% Since Last Earnings Report?

Inari Medical, Inc. (NARI) reported earnings 30 days ago. What's next for the stock?

4 months ago - Zacks Investment Research

3 High-Growth Healthcare Stocks to Buy in September

All three are rapidly expanding into their own corners of America's $4 trillion per year healthcare sector.

Other symbols:HIMSRNLX
4 months ago - The Motley Fool